OTHER NEWS - April 14, 1993
From Times Staff and Wire Reports
Schering-Plough Corp. received Food and Drug Administration approval for Claritin, a once-a-day hay fever drug that one analyst said could garner $500 million in annual worldwide sales.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
